Marinomed Biotech AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	20	35	27	44	85	130
Market Cap Growth	-19.99%	31.75%	-39.87%	-47.78%	-34.78%	-25.67%
Enterprise Value	31	45	47	63	98	140
Last Close Price	10.00	19.03	14.95	29.10	56.20	87.69
PE Ratio	1.02	1.95	-	-	-	-
Forward PE	6.71	3.41	11.11	-	-	-
PS Ratio	2.51	4.42	5.57	4.72	7.23	11.20
PB Ratio	-2.84	-4.99	-1.02	-3.52	-20.43	680.53
P/TBV Ratio	-	-	-	-	-	8983.04
EV/Sales Ratio	3.84	5.60	9.72	6.70	8.38	12.06
EV/EBITDA Ratio	-	928.37	-	-	-	-
Debt / Equity Ratio	-1.64	-1.64	-1.12	-1.71	-5.44	82.54
Debt / EBITDA Ratio	240.74	240.74	-	-	-	-
Net Debt / Equity Ratio	-1.51	-1.51	-1.05	-1.51	-3.48	52.23
Net Debt / EBITDA Ratio	220.92	220.92	-4.20	-3.42	-2.95	-1.89
Net Debt / FCF Ratio	-9.64	-9.64	-11.49	-5.14	-2.66	-1.73
Asset Turnover	1.13	1.13	0.47	0.54	0.54	0.52
Inventory Turnover	5.27	5.27	5.28	6.59	7.26	10.68
Quick Ratio	0.22	0.22	0.08	0.55	1.90	1.77
Current Ratio	0.25	0.25	0.10	0.66	2.40	2.14
Return on Equity (ROE)	-	-	-	-	-	-212.34%
Return on Assets (ROA)	-2.33%	-2.33%	-42.45%	-21.70%	-15.14%	-15.78%
Return on Invested Capital (ROIC)	-7.36%	-10.55%	-178.23%	-71.96%	-51.59%	-59.09%
Return on Capital Employed (ROCE)	-147.90%	-147.90%	29.90%	-219.80%	-32.40%	-36.90%
Earnings Yield	90.14%	51.27%	-57.79%	-14.35%	-7.53%	-4.52%
FCF Yield	-	-3.13%	-9.00%	-8.34%	-6.39%	-4.44%
Buyback Yield / Dilution	-3.46%	-3.46%	-17.14%	-1.29%	-1.56%	-0.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.